These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2646054)

  • 21. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ofloxacin vs ciprofloxacin: a comparison.
    Nicolau D; Quintiliani R; Nightingale CH
    Conn Med; 1992 May; 56(5):261-3. PubMed ID: 1611900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP; Jacobs F; Byl B
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
    Greenberg RN; Newman MT; Shariaty S; Pectol RW
    Antimicrob Agents Chemother; 2000 Jan; 44(1):164-6. PubMed ID: 10602739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New quinolones in the treatment of joint and bone infections.
    Desplaces N; Acar JF
    Rev Infect Dis; 1988; 10 Suppl 1():S179-83. PubMed ID: 3279491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose intravenous fluoroquinolones in the treatment of severe infections.
    Modai J
    J Chemother; 1999 Dec; 11(6):478-85. PubMed ID: 10678789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of quinolones against gram-positive cocci: clinical features.
    Giamarellou H
    Drugs; 1995; 49 Suppl 2():58-66. PubMed ID: 8549418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fluoroquinolones in skin and skin structure infections.
    Blondeau JM
    Am J Clin Dermatol; 2002; 3(1):37-46. PubMed ID: 11817967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
    Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.
    Bayer AS
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1102-10. PubMed ID: 2695331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections.
    Nikolaidis P
    Perit Dial Int; 1990; 10(2):127-33. PubMed ID: 2085597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of ciprofloxacin in patients with osteomyelitis associated with vascular insufficiency].
    García-Rosario LN; Ramírez-Ronda CH
    Bol Asoc Med P R; 1990 Mar; 82(3):125-8. PubMed ID: 2182039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and clinical results of parenterally administered new quinolones in humans.
    Lode H
    Rev Infect Dis; 1989; 11 Suppl 5():S996-1004. PubMed ID: 2672264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinolones in the treatment of serious infections.
    Webster A; Gaya H
    Rev Infect Dis; 1988; 10 Suppl 1():S225-33. PubMed ID: 3279496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
    D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
    J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolone therapy in the management of infection after irradiation.
    Brook I; Ledney GD
    Crit Rev Microbiol; 1992; 18(4):235-46. PubMed ID: 1524673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.